SC
Insider
Sandra Calvin
SVP, CHIEF ACCOUNTING OFFICERSandra Calvin (SVP, CHIEF ACCOUNTING OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.4M of TVTX (67,115 sh × $36.00, as filed), executed Nov 4 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$221K12,090 sh × $18.30
Exec Nov 25 2024
Filed Nov 25 2024 · 5:30 PM ET